The OCEANIC-AF trial has raised concerns about factor XI inhibitors. Should physicians still bet on this class of ...
Paris: Sanofi and CD&R have announced that they have signed the share purchase agreement in relation to the sale of a 50 ...
ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s diseaseNew detailed data from the RELIEVE UCCD ...
Sanofi Consumer Healthcare India Q4 Results 2025 on 21 Feb, 2025: Revenue decreased by 20.53% YoY & profit decreased by 34.66% YoY, profit at ₹44.3 crore and revenue at ₹170.7 crore.
For over a thousand people who undergo a stem cell or bone marrow transplant, survival comes at a cost: graft-versus-host disease (GvHD). 1 GvHD is a life-altering condition which affects 30 to 40 per ...
21h
Zacks.com on MSNIONS’ Better-Than-Expected Q4 ResultsEC approves MRK's Welireg for two indications. FDA grants priority review to SNY and REGN's Dupixent sBLA for bullous pemphigoid.
After turning over more than 1,300 documents to the Federal Trade Commission, the fast food giant is turning its attention to subpoenas from pharmacy benefit managers the agency accuses of ...
Publicis Groupe has acquired an influencer agency based in Brazil, expanding its presence in the Latin American market. The move aims to leverage the agency’s extensive network of over 500,000 ...
The American Pharmacists Association (APhA) has selected seven recipients of its 2025 Immunization Champion Awards, ...
Malgré les reculs politiques, de nombreuses grandes entreprises européennes publient déjà leurs reportings CSRD.
The PMCPA has turned party pooper, coming down on GSK after learning that a U.K. employee celebrated a post about a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results